Isofol Medical Management

How experienced are the management team and are they aligned to shareholders interests?

3.2yrs

Average management tenure


CEO

Jarl Jungnelius (71 yo)

2.83yrs

Tenure

kr5,068,000

Compensation

Dr. Jarl Ulf Jungnelius, M.D., Ph D., serves as Chief Executive Officer and Managing Director at Isofol Medical AB (publ) since November 13, 2019. Dr. Jungnelius serves as a Member of the Supervisory Board...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Jarl's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensation vs Earnings: Jarl's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: ISOFOL's management team is considered experienced (3.2 years average tenure).


Board Members

Experienced Board: ISOFOL's board of directors are considered experienced (3.3 years average tenure).